Pharmaceutical Executive, August 2022 Issue (PDF)

The provider hopes that this option will be a solution to the state’s primary care physician shortage.

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.

The company shifted several key presidents to adjust its global priorities.

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.